Nantahala Capital Management, LLC Fulcrum Therapeutics, Inc. Put Options Transaction History
Nantahala Capital Management, LLC
- $1.68 Billion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding FULC
# of Institutions
147Shares Held
52.1MCall Options Held
6.83MPut Options Held
1.83M-
Ra Capital Management, L.P. Boston, MA10.2MShares$36.4 Million0.51% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA5.25MShares$18.7 Million2.43% of portfolio
-
Black Rock Inc. New York, NY4.8MShares$17.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.27MShares$11.7 Million0.0% of portfolio
-
Trv Gp Iv, LLC Boston, MA2.34MShares$8.34 Million5.16% of portfolio
About Fulcrum Therapeutics, Inc.
- Ticker FULC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,038,900
- Market Cap $185M
- Description
- Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...